These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2558433)
1. Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil. Neal RA; van Bueren J; McCoy NG; Iwobi M Trans R Soc Trop Med Hyg; 1989; 83(2):197-8. PubMed ID: 2558433 [TBL] [Abstract][Full Text] [Related]
2. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate. Valiathan R; Dubey ML; Mahajan RC; Malla N Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137 [TBL] [Abstract][Full Text] [Related]
3. Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase. Carter KC; Hutchison S; Henriquez FL; Légaré D; Ouellette M; Roberts CW; Mullen AB Antimicrob Agents Chemother; 2006 Jan; 50(1):88-95. PubMed ID: 16377672 [TBL] [Abstract][Full Text] [Related]
4. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice. Roychoudhury J; Sinha R; Ali N PLoS One; 2011 Mar; 6(3):e17376. PubMed ID: 21423750 [TBL] [Abstract][Full Text] [Related]
5. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. Baillie AJ; Coombs GH; Dolan TF; Laurie J J Pharm Pharmacol; 1986 Jul; 38(7):502-5. PubMed ID: 2875149 [TBL] [Abstract][Full Text] [Related]
6. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani. Sinha R; Roychoudhury J; Palit P; Ali N Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907 [TBL] [Abstract][Full Text] [Related]
7. Studies on stibanate resistant Leishmania donovani isolates of Indian origin. Pal S; Mandal A; Duttagupta S Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284 [TBL] [Abstract][Full Text] [Related]
8. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection. Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162 [TBL] [Abstract][Full Text] [Related]
10. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani. Carter KC; Mullen AB; Sundar S; Kenney RT Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339 [TBL] [Abstract][Full Text] [Related]
11. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Escobar P; Yardley V; Croft SL Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640 [TBL] [Abstract][Full Text] [Related]
12. Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice. Carter KC; Dolan TF; Alexander J; Baillie AJ; McColgan C J Pharm Pharmacol; 1989 Feb; 41(2):87-91. PubMed ID: 2568434 [TBL] [Abstract][Full Text] [Related]
13. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice. Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361 [TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates. Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate. Baillie AJ; Coombs GH; Dolan TF; Hunter CA; Laakso T; Sjöholm I; Stjärnkvist P J Pharm Pharmacol; 1987 Oct; 39(10):832-5. PubMed ID: 2891821 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Mookerjee Basu J; Mookerjee A; Banerjee R; Saha M; Singh S; Naskar K; Tripathy G; Sinha PK; Pandey K; Sundar S; Bimal S; Das PK; Choudhuri SK; Roy S Antimicrob Agents Chemother; 2008 Mar; 52(3):1080-93. PubMed ID: 18056276 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice. Pal S; Ravindran R; Ali N Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135 [TBL] [Abstract][Full Text] [Related]
19. Primary agent for leishmaniasis. Berman JD Am J Trop Med Hyg; 1988 May; 38(3):652. PubMed ID: 2856321 [No Abstract] [Full Text] [Related]
20. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis. Martinez S; Looker DL; Berens RL; Marr JJ Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]